1. Home
  2. PODD vs AER Comparison

PODD vs AER Comparison

Compare PODD & AER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • AER
  • Stock Information
  • Founded
  • PODD 2000
  • AER 1995
  • Country
  • PODD United States
  • AER Ireland
  • Employees
  • PODD N/A
  • AER N/A
  • Industry
  • PODD Medical/Dental Instruments
  • AER Diversified Commercial Services
  • Sector
  • PODD Health Care
  • AER Consumer Discretionary
  • Exchange
  • PODD Nasdaq
  • AER Nasdaq
  • Market Cap
  • PODD 23.8B
  • AER 21.0B
  • IPO Year
  • PODD 2007
  • AER 2006
  • Fundamental
  • Price
  • PODD $328.37
  • AER $121.53
  • Analyst Decision
  • PODD Strong Buy
  • AER Strong Buy
  • Analyst Count
  • PODD 18
  • AER 7
  • Target Price
  • PODD $334.50
  • AER $122.57
  • AVG Volume (30 Days)
  • PODD 568.2K
  • AER 1.9M
  • Earning Date
  • PODD 11-06-2025
  • AER 10-29-2025
  • Dividend Yield
  • PODD N/A
  • AER 0.89%
  • EPS Growth
  • PODD N/A
  • AER 1.32
  • EPS
  • PODD 3.32
  • AER 15.88
  • Revenue
  • PODD $2,359,500,000.00
  • AER $7,984,195,000.00
  • Revenue This Year
  • PODD $29.18
  • AER $1.51
  • Revenue Next Year
  • PODD $18.09
  • AER $2.65
  • P/E Ratio
  • PODD $96.84
  • AER $7.57
  • Revenue Growth
  • PODD 26.00
  • AER 2.80
  • 52 Week Low
  • PODD $225.37
  • AER $85.57
  • 52 Week High
  • PODD $353.50
  • AER $125.45
  • Technical
  • Relative Strength Index (RSI)
  • PODD 48.78
  • AER 55.87
  • Support Level
  • PODD $313.24
  • AER $119.24
  • Resistance Level
  • PODD $351.94
  • AER $124.15
  • Average True Range (ATR)
  • PODD 10.31
  • AER 2.22
  • MACD
  • PODD -3.49
  • AER -0.56
  • Stochastic Oscillator
  • PODD 38.34
  • AER 36.39

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About AER AerCap Holdings N.V.

AerCap Holdings NV is an aircraft leasing company. Its activities include leasing, financing, sales, and management of commercial aircraft and engines. It also provides aircraft asset management and corporate services to securitization vehicles, joint ventures, and other third parties.It has one business segment: leasing, financing, sales and management of commercial flight equipment (Commercial Flight Equipment Segment).Through its subsidiary, the group also provides engine leasing, certified aircraft engines, airframes, and engine parts. Its geographical segments include United Kingdom, United States, and Other countries.

Share on Social Networks: